The 2023 data reveals significant differences in environmentally related tax revenue from pollution in chemical manufacturing across European countries. France leads with 62.24 million USD, followed by Spain and Hungary. Notably, the United Kingdom and Netherlands experienced declines of over 3% and 10%, respectively. In contrast, Ireland saw significant growth at over 38%. Belgium and Slovenia faced substantial reductions. The industry has seen varied performances, with stable growth in France and positive change in Latvia and Switzerland.
Future trends to watch include the impact of increasing environmental regulations across Europe, potential technological innovations reducing emissions, and the influence of economic policies on tax revenues. The push for green energy and sustainable practices might reshape the revenue structure in environmental taxation for these sectors in the coming years.
Top countries in Environmentally Related Tax Revenue from Taxes on Pollution in Manufacturing of Chemicals, Basic Pharmaceuticals and Preparations by Country
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 France | 62.24 | 2023 | +2.96% | +3.96% | View data |
| 2 | 2 Spain | 29.88 | 2023 | +10.53% | +3.7% | View data |
| 3 | 3 Hungary | 22.85 | 2023 | +5.04% | +0.42% | View data |
| 4 | 4 Netherlands | 20.8 | 2023 | +1.9% | -3.45% | View data |
| 5 | 5 United Kingdom | 9.16 | 2023 | -12.7% | -10.64% | View data |
| 6 | 6 Denmark | 7.29 | 2023 | +0.066% | -2.01% | View data |
| 7 | 7 Poland | 6.18 | 2023 | -3.03% | -2.34% | View data |
| 8 | 8 Czech Republic | 1.29 | 2023 | -10.59% | -8.64% | View data |
| 9 | 9 Switzerland | 0.72 | 2023 | +0.55% | +2.56% | View data |
| 10 | 10 Belgium | 0.71 | 2023 | -48.52% | -28.52% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
